112 related articles for article (PubMed ID: 22964933)
1. Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion.
Santos GT; Prolla JC; Camillo ND; Zavalhia LS; Ranzi AD; Bica CG
J Bras Pneumol; 2012; 38(4):487-93. PubMed ID: 22964933
[TBL] [Abstract][Full Text] [Related]
2. Impact of cell arrangement of pleural effusion in survival of patients with breast cancer.
Camillo ND; Dos Santos GT; Prolla JC; Flôres ER; Introíni GO; Brackmann RL; da Cruz IB; Bica CG
Acta Cytol; 2014; 58(5):446-52. PubMed ID: 25377597
[TBL] [Abstract][Full Text] [Related]
3. Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malignant plural effusion cells in human breast cancer.
Zhao ZJ; Ren HY; Yang F; Wang J; Wu GP; Mi XY
Diagn Cytopathol; 2015 Nov; 43(11):897-903. PubMed ID: 26331901
[TBL] [Abstract][Full Text] [Related]
4. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM
Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with breast cancer and malignant pleural effusion.
van Galen KP; Visser HP; van der Ploeg T; Smorenburg CH
Breast J; 2010; 16(6):675-7. PubMed ID: 21070453
[No Abstract] [Full Text] [Related]
6. Metastatic breast carcinoma in pleural fluid: Correlation of receptor and HER2 status with the primary carcinoma-a pilot study.
Francis IM; Alath P; George SS; Jaragh M; Al Jassar A; Kapila K
Diagn Cytopathol; 2016 Dec; 44(12):980-986. PubMed ID: 27666130
[TBL] [Abstract][Full Text] [Related]
7. Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor.
Pokieser W; Cassik P; Fischer G; Vesely M; Ulrich W; Peters-Engl C
Breast Cancer Res Treat; 2004 Jan; 83(2):139-42. PubMed ID: 14997044
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of CSN6 protein expression and correlation with mutant-type P53 protein in breast cancer.
Wang W; Tang M; Zhang L; Xu X; Qi X; Yang Y; Jin F; Chen B
Jpn J Clin Oncol; 2013 Dec; 43(12):1170-6. PubMed ID: 24106298
[TBL] [Abstract][Full Text] [Related]
9. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
[TBL] [Abstract][Full Text] [Related]
10. Survivin is a negative prognostic factor in malignant pleural effusion.
Arellano-Orden E; Romero-Romero B; Sánchez-López V; Martín-Juan J; Rodríguez-Panadero F; Otero-Candelera R
Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29359509
[TBL] [Abstract][Full Text] [Related]
11. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
12. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis.
Gaforio JJ; Serrano MJ; Sanchez-Rovira P; Sirvent A; Delgado-Rodriguez M; Campos M; de la Torre N; Algarra I; Dueñas R; Lozano A
Int J Cancer; 2003 Dec; 107(6):984-90. PubMed ID: 14601059
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of HER2-positive cell line derived from pleural effusion of human breast scirrhous carcinoma.
Tabei I; Nishiyama S; Yamashita S; Hashimoto H; Tachibana T; Uchida K; Ishikawa H
Hum Cell; 2008 Nov; 21(4):105-12. PubMed ID: 19067762
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
[TBL] [Abstract][Full Text] [Related]
15. Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.
Terra RM; Antonangelo L; Mariani AW; de Oliveira RL; Teixeira LR; Pego-Fernandes PM
Lung; 2016 Aug; 194(4):681-6. PubMed ID: 27300446
[TBL] [Abstract][Full Text] [Related]
16. Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.
Hsu LH; Hsu PC; Liao TL; Feng AC; Chu NM; Kao SH
BMC Cancer; 2016 Jul; 16():463. PubMed ID: 27411914
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
Bao QL; Li J; Sun W; Jiang HG; Zhu LR; Wang Y
Jpn J Clin Oncol; 2014 Dec; 44(12):1198-205. PubMed ID: 25425729
[TBL] [Abstract][Full Text] [Related]
18. [Survival of malignant and paramalignant pleural effusions in Ouagadougou].
Bambara AT; Ouédraogo SM; Maïga S; Sondo KA; Boncoungou/Nikièma K; Ouédraogo G; Koumbem B; Ouédraogo AS; Djibril M; Badoum G; Ouédraogo AR; Ouédraogo M
Rev Pneumol Clin; 2016 Dec; 72(6):346-352. PubMed ID: 27776946
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion.
Tseng YH; Ho HL; Lai CR; Luo YH; Tseng YC; Whang-Peng J; Lin YH; Chou TY; Chen YM
J Thorac Oncol; 2018 Mar; 13(3):447-453. PubMed ID: 29246835
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
